Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy: A meta-analysis

Journal of Human Genetics

Volumn 52, Issue 11, 2007, Pages 881-890

  Zintzaras, Elias ^a,b   Uhlig, Katrin ^c   Koukoulis, George N ^a   Papathanasiou, Afroditi A ^a   Stefanidis, Ioannis ^a  

^a UNIVERSITY OF THESSALY   (Greece)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TUFTS MEDICAL CENTER   (United States)

Author keywords

C677T; Diabetic nephropathy; Genetic epidemiology; Meta analysis; MTHFR; Polymorphism; Type 1 diabetes; Type 2 diabetes

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ALLELE; ARTICLE; BODY MASS; CASE CONTROL STUDY; DIABETIC NEPHROPATHY; DNA POLYMORPHISM; GENETIC HETEROGENEITY; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; RISK FACTOR; SENSITIVITY ANALYSIS;

DIABETIC NEPHROPATHIES; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 36148965526     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10038-007-0189-3     Document Type: Article

References (58)

1. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088-1101
2. Bluthner M, Bruntgens A, Schmidt S, Strojek K, Grzeszczak W, Ritz E (1999) Association of methylenetetrahydrofolate reductase gene polymorphism and diabetic nephropathy in type 2 diabetes? Nephrol Dial Transplant 14:56-57
3. Boger CA, Stubanus M, Haak T, Götz AK, Christ J, Hoffmann U, Riegger GA, Krämer BK (2007) Effect of MTHFR C677T genotype on survival in type 2 diabetes patients with end-stage diabetic nephropathy. Nephrol Dial Transplant 22:154-162
4. Borch-Johnsen K, Norgaard K, Hommel E, Mathiesen ER, Jensen JS, Deckert T, Parving HH (1992) Is diabetic nephropathy an inherited complication? Kidney Int 41:719-722
5. Bostom AG, Selhub J, Jacques PF, Rosenberg IH (2001) Power shortage: clinical trials testing the "homocysteine hypothesis" against a background of folic acid-fortified cereal grain flour. Ann Intern Med 135:133-137
6. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 274:1049-1057
7. Buysschaert M, Gala JL, Bessomo A, Hermans MP (2004) C677T methylene-tetrahydrofolate reductase mutation in type 2 diabetic patients with and without hyperhomocysteinaemia. Diabetes Metab 30:349-354
8. Chico A, Perez A, Cordoba A, Arcelús R, Carreras G, de Leiva A, González-Sastre F, Blanco-Vaca F (1998) Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease? Diabetologia 41:684-693
9. Clayton D, McKeigue PM (2001) Epidemiological methods for studying genes and environmental factors in complex diseases. Lancet 358:1356-1360
10. Constans J, Blann AD, Resplandy F, Parrot F, Seigneur M, Renard M, Amiral J, Guérin V, Boisseau MR, Conri C (1999) Endothelial dysfunction during acute methionine load in hyperhomocysteinaemic patients. Atherosclerosis 147:411-413
11. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177-188
12. Egger M, Davey SG, Schneider M, Minder C (1997a) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634
13. Egger M, Zellweger-Zahner T, Schneider M, Junker C, Lengeler C, Antes G (1997b) Language bias in randomised controlled trials published in English and German. Lancet 350:326-329
14. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111-113
15. Fujita H, Narita T, Meguro H, Ishii T, Hanyu O, Suzuki K, Kamoi K, Ito S (1999) No association between MTHFR gene polymorphism and diabetic nephropathy in Japanese type II diabetic patients with proliferative diabetic retinopathy. J Diabetes Complicat 13:284-287
16. Goyette P, Sumner JS, Milos R, Duncan AM, Rosenblatt DS, Matthews RG, Rozen R (1994) Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification. Nat Genet 7:195-200
17. Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T (2005) Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 28:164-176
18. Imperatore G, Hanson RL, Pettitt DJ, Kobes S, Bennett PH, Knowler WC (1998) Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima diabetes genes group. Diabetes 47:821-830
19. Ioannidis JP, Trikalinos TA, Zintzaras E (2006) Extreme between-study homogeneity in meta-analyses could offer useful insights. J Clin Epidemiol 59:1023-1032
20. Kang SS, Wong PW, Bock HG, Horwitz A, Grix A (1991) Intermediate hyperhomocysteinemia resulting from compound heterozygosity of methylenetetrahydrofolate reductase mutations. Am J Hum Genet 48:546-551
21. Ksiazek P, Bednarek-Skublewska A, Buraczynska M (2004) The C677T methylenetetrahydrofolate reductase gene mutation and nephropathy in type 2 diabetes mellitus. Med Sci Monit 10:BR47-BR51
22. Lau J, Antman EM, Jimenez-Silva J, Kupelnick B, Mosteller F, Chalmers TC (1992) Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med 327:248-254
23. Ma J, Stampfer MJ, Giovannucci E, Artigas C, Hunter DJ, Fuchs C, Willett WC, Selhub J, Hennekens CH, Rozen R (1997) Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res 57:1098-1102
24. Maeda M, Yamamoto I, Fujio Y, Azuma J (2003) Homocysteine induces vascular endothelial growth factor expression in differentiated THP-1 macrophages. Biochim Biophys Acta 1623:41-46
25. Makita Y, Moczulski DK, Bochenski J, Smiles AM, Warram JH, Krolewski AS (2003) Methylenetetrahydrofolate reductase gene polymorphism and susceptibility to diabetic nephropathy in type 1 diabetes. Am J Kidney Dis 41:1189-1194
26. McCully KS (1969) Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 56:111-128
27. McCully KS (1996) Homocysteine and vascular disease. Nat Med 2:386-389
28. Moczulski D, Fojcik H, Zukowska-Szczechowska E, Szydlowska I, Grzeszczak W (2003) Effects of the C677T and A1298C polymorphisms of the MTHFR gene on the genetic predisposition for diabetic nephropathy. Nephrol Dial Transplant 18:1535-1540
29. Mtiraoui N, Ezzidi I, Chaieb M, Marmouche H, Aouni Z, Chaieb A, Mahjoub T, Vaxillaire M, Almawi WY (2007) MTHFR C677T and A1298C gene polymorphisms and hyperhomocysteinemia as risk factors of diabetic nephropathy in type 2 diabetes patients. Diabetes Res Clin Pract 75:99-106
30. Neugebauer S, Baba T, Watanabe T (1998) Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy in NIDDM patients. Lancet 352:454
31. Odawara M, Yamashita K (1999): A common mutation of the methylenetetrahydrofolate reductase gene as a risk factor for diabetic nephropathy. Diabetologia 42:631-632
32. Passaro A, Calzoni F, Volpato S, Nora ED, Pareschi PL, Zamboni PF, Fellin R, Solini A (2003) Effect of metabolic control on homocysteine levels in type 2 diabetic patients: a 3-year follow-up. J Intern Med 254:264-271
33. Quinn M, Angelico MC, Warram JH, Krolewski AS (1996) Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia 39:940-945
34. Roybal CN, Yang S, Sun CW, Hurtado D, Vander Jagt DL, Townes TM, Abcouwer SF (2004) Homocysteine increases the expression of vascular endothelial growth factor by a mechanism involving endoplasmic reticulum stress and transcription factor ATF4. J Biol Chem 279:14844-14852
35. Shcherbak NS, Shutskaya ZV, Sheidina AM, Larionova VI, Schwartz EI (1999) Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy in IDDM patients. Mol Genet Metab 68:375-378
36. Shpichinetsky V, Raz I, Friedlander Y, Goldschmidt N, Wexler ID, Ben-Yehuda A, Friedman G (2000) The association between two common mutations C677T and A1298C in human methylenetetrahydrofolate reductase gene and the risk for diabetic nephropathy in type II diabetic patients. J Nutr 130:2493-2497
37. Smyth JS, Savage DA, Maxwell AP (1999) MTHFR gene polymorphism and diabetic nephropathy in type 1 diabetes. Lancet 353:1156-1157
38. Strojek K, Grzeszczak W, Morawin E, Adamski M, Lacka B, Rudzki H, Schmidt S, Keller C, Ritz E (1997) Nephropathy of type II diabetes: evidence for hereditary factors? Kidney Int 51:1602-1607
39. Sun J, Xu Y, Zhu Y, Lu H (2004) Genetic polymorphism of methylenetetrahydrofolate reductase as a risk factor for diabetic nephropathy in Chinese type 2 diabetic patients. Diabetes Res Clin Pract 64:185-190
40. Sung SH, Ziyadeh FN, Wang A, Pyagay PE, Kanwar YS, Chen S (2006) Blockade of vascular endothelial growth factor signaling ameliorates diabetic albuminuria in mice. J Am Soc Nephrol 17:3093-3104
41. Weir BS (1996) Genetic data analysis II: methods for discrete population genetic data. Sinauer, Sunderland
42. Whitehead A (2002) Meta-analysis of controlled clinical trials. Wiley, Chichester
43. Yoshioka K, Yoshida T, Umekawa T, Kogure A, Takakura Y, Toda H, Yoshikawa T (2004) Methylenetetrahydrofolate reductase gene polymorphism is not related to diabetic nephropathy in Japanese Type 2 diabetic patients. Diabet Med 21:1051-1052
44. Zintzaras E (2006a) Association of methylenetetrahydrofolate reductase (MTHFR) polymorphisms with genetic susceptibility to gastric cancer: a meta-analysis. J Hum Genet 51:618-624
45. Zintzaras E (2006b) Methylenetetrahydrofolate reductase gene and susceptibility to breast cancer: a meta-analysis. Clin Genet 69:327-336
46. Zintzaras E (2006c) C677T and A1298C methylenetetrahydrofolate reductase gene polymorphisms in schizophrenia, bipolar disorder and depression: a meta-analysis of genetic association studies. Psychiatr Genet 16:105-115
47. Zintzaras E (2007) Brain-derived neurotrophic factor gene polymorphisms and schizophrenia: a meta-analysis. Psychiatr Genet 17:69-75
48. Zintzaras E, Hadjigeorgiou GM (2004) Association of paraoxonase 1 gene polymorphisms with risk of Parkinson's disease: a meta-analysis. J Hum Genet 49:474-481
49. Zintzaras E, Hadjigeorgiou GM (2005) The role of G196A polymorphism in the brain-derived neurotrophic factor gene in the cause of Parkinson's disease: a meta-analysis. J Hum Genet 50:560-566
50. Zintzaras E, Ioannidis JP (2005a) Heterogeneity testing in meta-analysis of genome searches. Genet Epidemiol 28:123-137
51. Zintzaras E, Ioannidis JP (2005b) HEGESMA: genome search meta-analysis and heterogeneity testing. Bioinformatics 21:3672-3673
52. Zintzaras E, Kaditis AG (2007) Sleep-disordered breathing and blood pressure in children: a meta-analysis. Arch Pediatr Adolesc Med 161:172-178
53. Zintzaras E, Stefanidis I (2005) Association between the GLUT1 gene polymorphism and the risk of diabetic nephropathy: a meta-analysis. J Hum Genet 50:84-91
54. Zintzaras E, Chatzoulis DZ, Karabatsas CH, Stefanidis I (2005) The relationship between C677T methylenetetrahydrofolate reductase gene polymorphism and retinopathy in type 2 diabetes: a meta-analysis. J Hum Genet 50:267-275
55. Zintzaras E, Kitsios G, Stefanidis I (2006a) Endothelial NO synthase gene polymorphisms and hypertension: a meta-analysis. Hypertension 48:700-710
56. Zintzaras E, Rodopoulou P, Koukoulis GN (2006b) BsmI, TaqI, ApaI and FokI polymorphisms in the vitamin D receptor (VDR) gene and the risk of osteoporosis: a meta-analysis. Dis Markers 22:317-326
57. Zintzaras E, Koufakis T, Ziakas PD, Rodopoulou P, Giannouli S, Voulgarelis M (2006c) A meta-analysis of genotypes and haplotypes of methylenetetrahydrofolate reductase gene polymorphisms in acute lymphoblastic leukemia. Eur J Epidemiol 21:501-510
58. Zintzaras E, Stefanidis I, Santos M, Vidal F (2006d) Do alcohol-metabolizing enzyme gene polymorphisms increase the risk of alcoholism and alcoholic liver disease? Hepatology 43:352-361